Showing results (21-30 of 714) with videos related to
Sort By:
Pageof 72
Haematologica|April 27, 2023
Asciminib in chronic myeloid leukemia: a STAMP for expedited delivery?Sandeep Padala, Jorge CortesCurrent Opinion in Hematology|January 27, 2007
Optimal initial therapy for patients with newly diagnosed chronic myeloid leukemia in chronic phaseEhab Atallah, Jorge CortesJournal of the National Comprehensive Cancer Network : JNCCN|September 25, 2009
New agents in chronic myelogenous leukemiaJorge Cortes, Francis GilesExpert Opinion on Pharmacotherapy|April 2, 2008
Homoharringtonine for the treatment of chronic myelogenous leukemiaAlfonso Quintás-Cardama, Jorge CortesClinical Advances in Hematology & Oncology : H&O|May 27, 2006
Kinase inhibitors in chronic myelogenous leukemiaAlfonso Quintás-Cardama, Jorge CortesHematology/Oncology Clinics of North America|July 24, 2004
Clonal evolution in chronic myelogenous leukemiaJorge Cortes, Michael E O'DwyerDrugs of Today (Barcelona, Spain : 1998)|November 8, 2007
Nilotinib therapy in chronic myelogenous leukemiaAlfonso Quintas-Cardama, Jorge CortesCurrent Oncology Reports|August 15, 2009
Chronic myeloid leukemia in the tyrosine kinase inhibitor era: what is the best therapy?Alfonso Quintás-Cardama, Jorge CortesExpert Opinion on Investigational Drugs|June 14, 2008
Therapeutic options for patients with clonal and idiopathic hypereosinophiaAlfonso Quintás-Cardama, Jorge CortesJournal of Hematology & Oncology|November 29, 2013
Optimizing management of ruxolitinib in patients with myelofibrosis: the need for individualized dosingRuben A Mesa, Jorge CortesPageof 72